Project: Multidimensional interrogation of microvascular matrisome abnormalities in cerebral small vessel diseases

Acronym MatriSVDs (Reference Number: NEURON_CV-010)
Project Topic Cerebral small vessel diseases (cSVDs) are a leading cause of stroke and dementia with no mechanism-based treatments. We aim to provide novel insights into fundamental mechanisms underlying the loss of mural cells and remodeling of the microvascular extracellular matrix (ECM), the two major outcomes common to cSVDs. Our overarching hypothesis is that perturbations of the brain microvascular matrisome— the ensemble of ECM and associated proteins—are a convergent pathway in cSVDs. Our project is articulated around the novel complementary concepts that matrisome changes (i) result from phenotypic switching of vascular/perivascular cells in small brain vessels, (ii) contribute to the loss of mural cells and (iii) are a potential mechanism underlying small brain vessel resilience. Capitalizing on unique resources including multiple clinically relevant cSVD mouse models and large, deeply phenotyped population-based cohorts with extensive molecular characterization, we will: 1) scrutinize phenotypic switching of vascular /perivascular cells in several cSVD mouse models at the single cell level, 2) elucidate the contribution of the HTRA1 matrisome protein in the clinical manifestations and pathogenesis of cSVDs and 3) identify matrisome genes involved in resilience mechanism to cSVD stressors. Each of the 3 aims has the potential to provide entirely new mechanistic insights, a trove of new research questions to explore and therapeutic avenues for these devastating diseases.
Network NEURON Cofund2
Call Neuron Cofund2 Joint Call 2022

Project partner

Number Name Role Country
1 Inserm U1266, Insitute of Psychiatry and Neurosciences of Paris Coordinator France
2 Institute for Stroke and Dementia Research Partner Germany
3 Dept. of Neurosurgery Partner Switzerland
4 Bordeaux Population Health Research Centre Partner France